최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기환경독성학회지 = Journal of environmental toxicology, v.19 no.4 = no.47, 2004년, pp.389 - 399
박종안 (순천향대학교 환경보건학과) , 여은영 (순천향대학교 환경보건학과) , 남상훈 (순천향대학교 환경보건학과) , 장봉기 (순천향대학교 환경보건학과) , 이종화 (순천향대학교 환경보건학과) , 김완종 (순천향대학교 생물학과)
Metallothionein (MT), a small protein molecule which can bind or release metal ions, is involved in the regulation of cellular metal homeostasis. This study was investigated the accumulation of cadmium in blood, tissue (liver, kidney and brain), and the effect of cadmium on several key genes (MT-I, ...
김남송. 전처치 기간에 따른 흰쥐의 조직내 카드뮴 및 metallothionein 생성에 관한 연구. Korean J Toxicol 1997; 13(1-2): 103-110
김판기. 카드뮴이 랫드에 미치는 독성학적 변화에 관한 연구. 용인대학교 논문집 1997; 13: 507-510
이순재. 급성 카드뮴 중독 흰쥐 간조직에서의 유리기 생성계의 활성화와 조직손상. 대구효성카톨릭대학교 석사학위논문집 1998; 58: 240-242
임순혁. Cadmium 투여에 의한 흰쥐의 간, 신장 및 혈액에서의 축적에 관한 연구. 청주대학교 석사학위논문.; 1992. pp. 5-6
Abuja PM and Albertini R. Methods for monitoring Oxida-tive stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta 2001; 306(1-2): 1-7
Adams JD Jr. Klaidman LK, Chang ML and Yang J. Brain oxidative stress-analytical chemistry and thermody-namics of glutathione and NADPH. Curr Top Med Chem 2001; 1(6): 473-482
Angelo A Valois and William S Webster. The choroid plexus as a target site for cadmium toxicity following chronic exposure in the adult mouse. An ultrastructural study. Toxicology 1989; 55(1-2): 193-205
Arlt S, Kontush A, Muller-Thomsen T and Beisiegel U. Lipid peroxidation as a common pathomechanism in Cor-onary heart disease and Alzheimer's disease. Gerontol Geriatr 2001; 34(6): 461-465
Arranz MA, Perez MI, Saiz-VadiIlo MC, Basagoiti I, Katarneh SM, Ribas B and Cadorniaa R. Pharmaco-kinetics of cadmium-109 in blood and brain structure of the rat. Rev Esp 1984; 40(3): 365-370
Arvidson B and Tjalve H. Distribution of 109Cd in the nervous system of rats after intravenous injection. Acta Neuropathol(Berl) 1986; 69(1-2): 111-116
Atsushi Takeda, Sachiyo Takefuta, Hiromi Ijiro, Shoji Okada and Naoto Oku. 109Cd transport in rat brain. Brain Research Bulletin 1999; 49(6): 453-457
Berg JW and Burbank F. Correlation between carcinogenic trace metals in water supplies and cancer mortality. Ann N.Y Acad Sci.; 1972. pp. 249-262
Cantilena LR and Klaassen CD. Comparison of the effecti-veness of several chelators after single administration on the toxicity, distribution and excretion of cadmium. Toxicol Appl Pharmacol 1981; 58: 452-460
Choudhuri S, McKim JM Jr and Klaassen CD. Differential expression of the metallothionein gene in liver and brain of mice and rats. Toxicol appl Pharmacol 1993; 119: 1-10
Clausen J and Rastogi SC. Heavy metal pollution among autoworkers, lead. Bri J Ind med 1977; 34: 208-215
Coyle P, Philcox JC, Carey LC and Rofe AM. Metallothionein: The multipurpose protein. CMLS Cell Mol Life Sci 2002; 59: 627-647
Cuthbert OS. Metallothionein in human disease. Cellular and Molecular Biology 2000; 46(2): 465-488
Deaven LL and Campbell EW. Factors affecting the induc-tion of chromosomal aberrations by cadmium in Chinese hamster cells. Cytogenet Cell Genet 1980; 26: 251-260
Dudley RE, Svovoda DJ and Klaassen CD. Acute exposure to cadmium causes severe liver injury in rats. Toxicol Appl Pharmacol 1982; 65: 302-313
Evans J and Hastings L. Accumulation of Cd (II) in the CNS depending on the route of administration: intraperitoneal, intratracheal, or intranasal. Fundam Appl Toxicol Aug 1992; 19(2): 275-278
Faeder EJ, Chanet SQ and King LC. Biochemical and uItras-tructural changes in livers of cadmium treated rats. Toxi-col Appl Pharmacol 1977; 39: 473-483
Figueiredo-Pereira ME and Cohen G. The ubiquitin/ Proteasome pathway: friend or foe in zinc-, cadmium-, and $H_2O_2$ -induced neuronal oxidative stress. Mol Biol Rep 1999; 26(1-2): 65-69
Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. Mol Neurosci 2001; 17(2): 137-145
Goyer RA. Toxic effects of metals. In: Klassen CD, Amdur MO and Doull J (eds.), Casarett and Doull's Toxicology., 5th Ed., Macmillan Publishing Co., New york.; 1996. pp. 699-702
Grundman M. Vitamin E and Alzheimer disease: The basis for additional clinical trials. Clin Nutr 2000; 71(2): 630-636
Hammond PB and Foulkes EC. Metal ion toxicity in man and animals, In: Siegel, H.(ed.), Metal Ions in Biological Systems. Marcel Dekker, New York 1994; 20: 177-182
K $\"a$ gi JHR and Schaffer A. Biochemistry of metallothionein. Biochemistry 1988; 27: 8509-8515
Kanski J, Varadarajan S, Aksenova M and Butterfield DA. Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide l-42-associated oxidative stress and neurotoxicity. Biochim Biophys Acta 2002; 1586 (2): 190-198
Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, Vihalemm T, Kairane C and Zilmer M. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense. Neuro-chem Res 2001; 26(4): 353-361
Keen CL and Hurley LS. Zinc and reproduction: Effects of deficiency on fetal and postnatal development, in Zinc and Human Biology. Springer-Verlag London.; 1989. pp. 183-200
Kolonel L and Winkelstein W Jr. Cadmium and prostatic carcinoma. Lancet 1977; 2: 566-567
Kumar R, Agarwal A and Seth PK. Oxidative stress-medi-ated neurotoxicity of cadmium. Toxicol Letters 1996; 89: 65-69
Langmade SJ, Ravindra R, Daniels PJ and Andrews GK The transcription factor MTF-l mediates metal regulation of the mouse ZnTl gene. J Biol Chem 2000; 275: 34803-34809
Lui E, Fisman M, Woung C and Diaz F. Metals and the liver in Alzheimer's disease. An investigation of hepatic zinc, copper, cadmium, and metallothionein. Am Geriatr Soc 1990; 38(6): 633-639
Malcolm D. Cadmium as a carcinogen, In: Cadmium toxi-city. MennearJH.; 1979. pp. 173-180
Math PC and Gordon JL. Zinc metabolism in the brain relevance to human neurodegenerative disorders. Neuro-biology of Disease 1997; 4: 137-169
McMahon RJ and Cousins RJ. Regulation of the zinc trans-porter ZnT-1 by dietary zinc. Proc Natl Acad Sci 1998; 95: 4841-4846
O'Riordan ML, Hughes EG and Evans HJ. Chromosome studies on blood lymphocytes of men occupationally exp-osed to cadmium. Mutat Res 1978, 58: 305-311
Palmitier RD, Findley SD, Whitmore TE and Durnam DM. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci 1992; 89: 6333-6337
Panayi Ae, Spyrou NM, Iversen BS, White MA and Part P. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass Spectrometry. Neurol Sci 2002; 195(1): 1-10
Pitchumoni SS, Doraiswamy PM. Current status of antioxi-dant therapy for Alzheimer's Disease. Am Geriatr Soc 1998; 46 (12): 1566-1572
Risso-de Faverney C, Devaux A, Lafaurie M, Girard JP, Bailly B and Rahmani R. Cadmium induces apotosis and genotoxicity in rainbow trout hepatocyte through generation of reactive oxygen species. Aquat Toxicol 2001; 53(1): 65-76
Roels HA, Lauwery RR, Buchet JP, Bernard A, Chettle DR, Harrey TC and AI-Haddad IK. In vivo measurement of liver and kidney cadmium in workers exposed to this metal: Its significance with repect to cadmium in blood and urine. Environ Res 1981; 26: 217-240
Schrauzer GN, White DA and Schneider CJ. Cancer morta-lity correlation studies. IV. Associations with dietary intakes and blood levels of certain trace elements, notal-by Se-antagonists. Bioinorg Chem 1972; 7: 35-36
Sendelbach LE and Klaassen CD. Kidney synthesizes less metallothionein than liver in response to cadmium Chlo-ride and cadmium metallothionein. Toxicol Appl Phar-macol 1988; 92: 95-102
Shaikh ZA and Lucis UJ. Cadmium and zinc binding in mammalian liver and kidneys. Arch Environ health 1972; 24: 419-425
Shukla A, Shukla GS and Srimal RC. Cadmium-induced alterations in blood-brain barrier permeability and its possible correlation with decreased microvessel antioxi-dant potential in rat. Human & Experimental Toxicology 1996: 15(5): 400-405
Snyder WS, Cook MJ, Nasset ES, Karhausen LR, Howells GP and Tipton IH. International Commission on Radio-logical Protection. Report of the task group on reference man. New York. ICRP Publication 23.; 1975
Szuster-Ciesielska A, Stachura A, Slotwinska M, Kaminska T, Sniezko R, Paduch R, Abramczyk D, Filar J and Kan defer-Szerszen M. The inhibitory effect of zinc on Cadi-mium-induced cell apotosis and reactive oxygen species production in cell cultures. Toxicology 2000; 145 (2-3): 159-171
Taubeneck MW, Daston GP, Rogers JM and Keen CL. AI-tered maternal zinc metabolism following exposure to diverse developmental toxicants. Repro Toxicol 1994; 8: 25-40
Taubeneck MW, Daston GP, Rogers JM, Gershwin ME, Ansari A and Keen CL. Tumor necrosis factor-alpha alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. J Nutr 1995; 125: 908-919
Uchida Y, Takio K, Titani K, Ihara Y and Tomonaga M. The growth inhibitory factor that is deficient in the AIzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991; 7: 337-347
Webster WS. Cadmium induced fetal growth retardation in the mouse. Arch Environ Health 1978; 32: 16-22
WHO (World Health Organization). Cadmium-environ-mental aspects. Environmental Health Criteria 135.; 1992
Wong KL and Klaassen CD. Tissue retention of cadmium in rats during postnatal development. Toxicol Appl Phar-macol 1980; 53: 343-353
Wong KL and Klaassen CD. Neurotoxic effects of cadmium in young rats. Toxicol Appl Pharmacol 1982; 63: 330-33
Wren CD, Harris S and Haittrup N. Ecotoxicology of mer-cury and cadmium, In: Handbook of ecotoxicology. Hoff-man DS, Rattner BA, Burton GA, Jr and J caims, Jr (Eds.), CRC Press, Boca Raton.; 1995. pp. 392-423
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.